These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28030535)

  • 21. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
    Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
    Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a 2-Point Limited Sampling Strategy to Predict the Tacrolimus Area-Under-the-12-Hour-Curve in Kidney Transplant Recipients.
    Vadcharavivad S; Susomboon T; Kulabusaya B; Avihingsanon Y; Praditpornsilpa K; Townamchai N
    Ther Drug Monit; 2016 Oct; 38(5):614-20. PubMed ID: 27328329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A limited sampling method for estimation of the etoposide area under the curve.
    Strömgren AS; Sørensen BT; Jakobsen P; Jakobsen A
    Cancer Chemother Pharmacol; 1993; 32(3):226-30. PubMed ID: 7684658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited Sampling Strategies Supporting Individualized Dose Adjustment of Intravenous Busulfan in Children and Young Adults.
    Teitelbaum Z; Nassar L; Scherb I; Fink D; Ring G; Lurie Y; Krivoy N; Bentur Y; Efrati E; Kurnik D
    Ther Drug Monit; 2020 Jun; 42(3):427-434. PubMed ID: 31479045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration-Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia.
    Adawi DH; Fredj NB; Al-Barghouthi A; Dridi I; Lubada M; Manasra M; Aouam K
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):43-55. PubMed ID: 38006575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
    Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
    Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.
    Saint-Marcoux F; Guigonis V; Decramer S; Gandia P; Ranchin B; Parant F; Bessenay L; Libert F; Harambat J; Bouchet S; Broux F; Compagnon P; Marquet P
    Pharmacol Res; 2011 May; 63(5):423-31. PubMed ID: 21272643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.
    Salinger DH; Blough DK; Vicini P; Anasetti C; O'Donnell PV; Sandmaier BM; McCune JS
    Clin Cancer Res; 2009 Aug; 15(16):5280-7. PubMed ID: 19671874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Dupuis LL; Sibbald C; Schechter T; Ansari M; Gassas A; Théorêt Y; Kassir N; Champagne MA; Doyle J
    Biol Blood Marrow Transplant; 2008 May; 14(5):576-82. PubMed ID: 18410900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients.
    Chen CL; Rawwas J; Sorrell A; Eddy L; Uckun FM
    Leuk Lymphoma; 2001 Jul; 42(3):317-27. PubMed ID: 11699396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approach.
    Salinger DH; McCune JS; Ren AG; Shen DD; Slattery JT; Phillips B; McDonald GB; Vicini P
    Clin Cancer Res; 2006 Aug; 12(16):4888-98. PubMed ID: 16914577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualizing oral busulfan dose after using a test dose in patients undergoing hematopoietic stem cell transplantation: pharmacokinetic characterization.
    Effting C; de Moraes Arantes A; Queiroz Labre LV; Carneiro WJ; de Oliveira Neto JR; Bariani C; Rodrigues CR; Rodrigues AR; Cunha LC
    Ther Drug Monit; 2015 Feb; 37(1):66-70. PubMed ID: 25588069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of sampling time deviations on the prediction of the area under the curve using regression limited sampling strategies.
    Sarem S; Nekka F; Ahmed IS; Litalien C; Li J
    Biopharm Drug Dispos; 2015 Oct; 36(7):417-28. PubMed ID: 25845479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.
    Langers P; Press RR; Inderson A; Cremers SC; den Hartigh J; Baranski AG; van Hoek B
    Ther Drug Monit; 2014 Apr; 36(2):141-7. PubMed ID: 24081208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
    Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
    J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.